Alzheimer's Disease Trial, Recruiting (NCT05741853)

Alzheimer's Disease Trial, Recruiting NCT05741853 Sponsor: Stephanie Grasso Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05741853 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Primary Progressive Aphasia (PPA), a condition that affects language and communication
You speak both Spanish and Catalan, or both Spanish and English
You do not need to be equally good in both languages — any level of experience in each language is acceptable
If joining the treatment part of the study: you score 15 or higher on a standard memory and thinking test called the Mini-Mental State Examination
If joining the assessment-only part of the study: you score 10 or higher on the Mini-Mental State Examination

Who may not be able to join:

You have another brain or nervous system condition, or other medical condition, that could be causing similar symptoms
You have a psychiatric condition that could be causing similar symptoms
You have significant vision or hearing problems that have not been corrected and would make it hard to take part
Your main early symptoms involve difficulties with thinking, behaviour, or movement rather than language (confirm with trial site)
If joining the treatment part of the study: you score below 15 on the Mini-Mental State Examination
If joining the assessment-only part of the study: you score below 10 on the Mini-Mental State Examination

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephanie M Grasso, Ph.D, University of Texas at Austin

Phone: 512-471-4119

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05741853

Sponsor: Stephanie Grasso

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: 512-471-4119

More information: https://clinicaltrials.gov/study/NCT05741853

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Primary Progressive Aphasia (PPA), a condition that affects language and communication
You speak both Spanish and Catalan, or both Spanish and English
You do not need to be equally good in both languages — any level of experience in each language is acceptable
If joining the treatment part of the study: you score 15 or higher on a standard memory and thinking test called the Mini-Mental State Examination
If joining the assessment-only part of the study: you score 10 or higher on the Mini-Mental State Examination

Who may not be able to join:

You have another brain or nervous system condition, or other medical condition, that could be causing similar symptoms
You have a psychiatric condition that could be causing similar symptoms
You have significant vision or hearing problems that have not been corrected and would make it hard to take part
Your main early symptoms involve difficulties with thinking, behaviour, or movement rather than language (confirm with trial site)
If joining the treatment part of the study: you score below 15 on the Mini-Mental State Examination
If joining the assessment-only part of the study: you score below 10 on the Mini-Mental State Examination

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stephanie Grasso

Registry

ClinicalTrials.gov

Start date

1 May 2023

Est. completion

30 November 2027

Where this trial is recruiting

🇪🇸 Spain 🇺🇸 United States

Primary endpoints

Percent correct intelligible words from trained/untrained scripts; Percent correct spoken naming of trained/untrained nouns

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov